Editor's Top Picks
Submit Your Paper to GMJ
Inhaled Treprostinil Shows Promise in Advanced Pulmonary Fibrosis: Phase 3 Trial Results
A phase 3 clinical trial published in The New England Journal of Medicine shows that inhaled treprostinil reduces the decline…
RTS,S Malaria Vaccine’s Antibody Fingerprint Reveals Key to Improved Protection in African Children
Post hoc analysis of the RTS,S malaria vaccine trial reveals that children with high antibody responses to specific epitopes (NANP2…
First-Trimester NSAIDs and Birth Defects: Large Cohort Study Finds No Increased Risk
A population-based cohort study of 54,000 pregnancies found no increased risk of major congenital malformations associated with first-trimester NSAID exposure,…
Dexcom Signals Expansion Beyond Diabetes as CGM Technology Reshapes Health Monitoring
Dexcom's leadership has signalled plans to expand continuous glucose monitoring beyond diabetes management into weight and metabolic health applications. The…
TrumpRx Expands Generic Drug Portfolio Through Amazon Pharmacy and GoodRx Partnership
TrumpRx has partnered with Amazon Pharmacy and GoodRx to expand into generic medications, signaling a major shift in its pharmaceutical…
New R&D Ranking Reveals Sharp Disparities in Pharmaceutical Innovation Efficiency
A new evidence-based ranking of pharmaceutical companies reveals significant disparities in how efficiently firms convert R&D spending into drug approvals.…
New treatment approach offers hope for pre-eclampsia, a leading cause of maternal death
Pre-eclampsia causes more than 70,000 maternal deaths annually worldwide. Researchers are now investigating novel therapeutic approaches targeting placental dysfunction and…
Why Some Cancers Evade Chemotherapy: New Mechanism Identified
Researchers have identified a molecular mechanism that enables cancer cells to survive chemotherapy, revealing how 30–40% of treated tumors develop…